Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Exchange Rate Effect (2016 - 2025)

Kiora Pharmaceuticals' Exchange Rate Effect history spans 11 years, with the latest figure at $18755.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 124.85% year-over-year to $18755.0; the TTM value through Dec 2025 reached $173634.0, up 403.39%, while the annual FY2025 figure was $173634.0, 403.39% up from the prior year.
  • Exchange Rate Effect reached $18755.0 in Q4 2025 per KPRX's latest filing, up from $13154.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $131582.0 in Q2 2025 to a low of -$75485.0 in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $6446.8, with a median of $6979.0 recorded in 2024.
  • The largest YoY upside for Exchange Rate Effect was 4943.93% in 2021 against a maximum downside of 21713.45% in 2021.
  • A 5-year view of Exchange Rate Effect shows it stood at -$27132.0 in 2021, then soared by 242.54% to $38675.0 in 2022, then soared by 215.93% to $122184.0 in 2023, then plummeted by 161.78% to -$75485.0 in 2024, then surged by 124.85% to $18755.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Exchange Rate Effect are $18755.0 (Q4 2025), $13154.0 (Q3 2025), and $131582.0 (Q2 2025).